📰 Presents News
Page 171 - Presents News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Presents. Real-time updates on events, politics, business and more.
May 19, 2022
New free-of-charge accelerator package for ARIS is launched as the brand celebrates its 30th birthday Software AG today announced ARIS for sustainability, a new package that supports the planning
May 19, 2022
Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announces the presentation of preclinical data at the 59th Congress of the European
May 18, 2022
New Delhi [India], May 18 (ANI/GPRC): DMITRI is formed by an event Company known as Proventus Consulting Founder Raina Natasha Sequera in association with 3 Partners collaborating for an Event on DMITRI Dr Neeta Mhatre Mishra Founder of Reachout along with Imran Khan Founder of Tobewed and Sameer Salmani Founder of Sameer Salmanithe artist - Hair makeup Saloon and academy
May 18, 2022
NACON PRESENTS AN AMBITIOUS LINEUP AND ANNOUNCES TWO NEW GAMES NACON has confirmed its status as a major mid-publisher and creator of standard-setting accessories Paris
May 18, 2022
The local market is positioned to outperform amid the improving economic environment, an investment manager has predicted. The tide has now turned for value stocks both locally and globally, active e
May 18, 2022
Westport Country Playhouse presents a script-in-hand playreading of "The Scream: A Musical Comedy Fantasy"
May 17, 2022
AviadoBio Presents Preclinical Data at ASGCT 2022 Demonstrating that AVB-101 Represents a Novel and Promising Approach to the Treatment of Frontotemporal Dementia Intrathalamic
May 17, 2022
Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE: PM) Chief Financial Officer, Emmanuel Babeau, will address investors today at the Goldman Sachs Global Staples Forum in New York.
May 17, 2022
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces
May 15, 2022
New analyses of data from the Phase 3 EMPOWUR Extension Study of GEMTESA (vibegron) 75 mg provided additional insight into the long-term effects of the product. These data were featured in podium